“It not only showed darolutamide’s significant efficacy in preventing the spread of prostate cancer, but also its favorable tolerability profile that, once approved, may allow patients to continue their day-to-day life without adding any burden.” Karim Fizazi, M.D., Ph.D., Professor of Medicine at the Institut Gustave Roussy, University of Paris Sud, France
Mika Viitanen fell ill with prostate cancer at an exceptionally young age. The illness that had been in hiding in his body for a long time turned into a long-term guest.
Thanks to biosimilars, an increasing number of patients can receive effective care at a lower pharmaceutical cost.
Orion Research Foundation sr is distributing EUR 1,004,800 in research grants based on applications for 2019.
A list of recent posters presented at congresses and articles published in peer reviewed scientific journals.
6 Feb 2019 I Financial Statement Release for 2018 and related materials now published.
The 2019 Annual General Meeting will be held on 26 March 2019 in Helsinki. Registration closes on 20 March. Instructions and registration link can be found on these pages.
|2/6/2019||The Board of Directors of Orion Corporation decided on an incentive plan for key persons|
|2/6/2019||Notice to the Annual General Meeting of Orion Corporation|
|2/6/2019||Orion Group Financial Statement Release for 2018|
|1/9/2019||Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2019 AGM of Orion Corporation|
Pharmaceutical ingredients must be pure, which is why the washing of the production equipment is controlled closely. The work of Quality Control Chemist Tomi Svahn is related to the cleanliness of equipment and pharmaceutical ingredients.
Orion is the largest employer in the Finnish pharmaceutical industry. It is considered to be a good and reliable employer, which is also indicated by its lower-than-average employee turnover.
How do I apply for a job at Orion? Can I attach my CV to the application form? How can I make sure my job application stands out from the rest? These following tips will help you complete your job application.
One key area of Orion's business is Critical Care. Our portfolio includes Simdax® for acute heart failure and Precedex® and Dexdor® for sedation. Read more about Orion's proprietary products and other human pharmaceuticals.